Another limitation is the focus on change in drug absorption, whereas other PK parameters can be considered
This is not a routine test, but it is on my radar for specific patients whose B12 deficiency is severe or does not respond as expected to supplementation
If regulatory submissions proceed as expected, the earliest plausible timeline for a market authorisation decision in the UK or Europe would be 2026 or 2027 though this is subject to the pace of regulatory review, the completeness of the submission package, and any additional data requests from the MHRA or EMA
Since most organisms retained only one gene, the duplication observed in some specific organisms probably derives from isolated events
The test checks for two types of autoantibodies: Blocking autoantibodies (that BLOCK folate from getting into the cell) Binding autoantibodies (that clump together and therefore make it more difficult to adhere to the folate receptor.) This 2023 paper discusses the higher the binding autoantibodies, the better the response to leucovorin (prescription high-dose folinic acid)
It has been created without stimulants for those women who do not want to add caffeine or other nootropics to their daily routine
